Community/Retail

The Israel Institute for Biological Research presented the country’s Defense Minister Naftali Bennet with a “significant breakthrough” in the search for an antidote to COVID-19 on Monday night.

A recent survey identified the most substantial barriers to routine monitoring and follow-up for diabetes patients.

Lifestyle classes, or cardiac rehabilitation, are typically offered to heart attack patients unless the patient has a particular reason why it is not suitable for them.

Suzanne Soliman, PharmD, BCMAS, founder of Pharmacist Moms Group, discusses the power of social media to advance the field of pharmacy.

A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).

A rapid increase in telemedicine during the coronavirus disease 2019 pandemic could transform the way care is provided in the United States going forward.

Baker and her co-authors used federal employment data to find that 10% of US workers are employed in occupations in which exposure to disease or infection happens at least weekly based on employee and employer self-reports.

The findings of a recent survey from ValuePenguin found that 55% of the 1200 respondents said their mental health is suffering because of COVID-19, more specifically in millennials (63%) and parents with younger children (64%).

CPP is a rare disease defined as the onset of puberty before age 8 years in girls and before age 9 years in boys.

What is causing a patient's outbreak of psoriasis?

The APhA’s program “Addressing the COVID-19 Crisis: An Open Forum Webinar Series for Pharmacists” addressed the new conditions, including that hand sanitizer is compounded according to the following formula consistent with World Health Organization recommendations.

A new collaboration agreement was made between Moderna, Inc, and Lonza Ltd, to manufacture Moderna’s mRNA vaccine against the coronavirus disease 2019.

If the majority of Americans were diagnosed with COVID-19, the total cost of hospitalizations, ventilators, and other resources could cost $654 billion.

The FDA has granted Bio-Rad Laboratories Emergency Use Authorization for the company’s SARS-CoV-2 Total Ab test.

Gregory Leighton, RPh, vice president of clinical solutions and patient access for Asembia, addresses how the specialty pharmacy model can be applied to the retail channel.

Engaging in discussions with patients at high risk of complications from COVID-19 without seeming patronizing is an important skill that many pharmacists should practice.

Government officials have said it may be possible to reduce the United States’ dependence on other countries, but that it would be extremely complicated and difficult.

Survey finds pharmacists are mostly content with their compensation, but only moderately happy with their jobs

Pharmacy managers can promote a culture of safety that helps to reduce medication errors.

The STRIP examined the benefits of promoting cardiovascular health by dietary counseling from infancy to early adulthood.

Jeremy Sasser, CPhT, pharmacy content strategist for the National Healthcareer Association, discusses the role of technicians during and after COVID-19.

Several national pharmacy chains are preparing to roll out testing for COVID-19 in the coming weeks, including Health Mart, Kroger Co, and other chain pharmacies.

The Caring for Each Other initiative will include a Sesame Street video that features the Muppets thanking “Super Families.”

The COVID-19 pandemic shows that pharmacists can serve as nationally recognized providers and can contribute greatly to policy as it pertains to disease management, outbreaks, and workplace safety.

The 7 hardest-hit states all have mortality rates between 113% and 172% higher than normal, while New York City’s death rate is 325% higher than usual.

Efinaconazole was first approved by the FDA in June 2014 for patients 18 and older.

Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.

The MVA-MERS-S vaccine is based on an attenuated virus, modified vaccinia virus Ankara, which had previously been used in a smallpox eradication vaccination campaign.